SPRINT PNS System

Low-risk. Non-surgical. Durable.*

Uniquely designed to selectively stimulate targeted peripheral nerve fibers for up to 60 days, the SPRINT PNS System delivers a low-risk, non-surgical, minimally invasive and drug-free pain treatment option proven in clinical studies to provide significant and sustained relief from moderate to severe acute and chronic pain.

*Multiple clinical trials have demonstrated that the SPRINT PNS System can provide sustained pain relief well beyond the end of treatment for 12 months, and in some cases, participants report still having meaningful pain relief for almost five years following the 60-day treatment.^1-6

Short-term, 60-day treatment
Potential for durable relief
No permanent implant
Minimally invasive and drug-free
Non-destructive, motor-sparing

Download the Brochure

Clinically proven pain relief

In clinical studies, the vast majority of SPRINT PNS patients reported significant and sustained relief of pain and/or pain interference.^{1-5, 7-11,^}

Backed by the largest review of real-world PNS data

The largest retrospective review of real-word PNS data of over 6,100 patients, with over 71% demonstrating significant pain relief and/or improvement in quality of life following 60-day percutaneous PNS treatment with the SPRINT PNS System.^12,†,‡

Explore The Evidence

Head / Neck

Shoulder

Back

Hand

Knee

Foot & Ankle

Head-to-toe Treatment Options™

SPRINT PNS may be a solution for a wide variety of moderate-to-severe pain conditions, including:

Chronic back pain

Chronic headache and neck pain

Non-operable joint pain

Postoperative pain

Post-amputation pain

Neuropathic pain

Pain due to nerve trauma

The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves.

First-Line PNS™ treatment

The SPRINT PNS System is a patient-preferred**, low risk alternative to more invasive treatments such as ablation, permanent implants, or surgery. Our breakthrough First-Line PNS treatment is shown to provide significant and sustained pain relief in clinical studies when prior treatments such as opioids or injections have failed.

Patient-preferred** treatment

As the least invasive implantable PNS available, the SPRINT PNS System delivers the approach to pain relief patients prefer.

Smallest diameter PNS lead available

60-day PNS (e.g. SPRINT PNS System) preferred by patients to radiofrequency ablation

Only FDA-cleared implantable PNS system that does not require incisions or a permanent implant

^{^}In clinical studies, the most common adverse events were skin irritation and erythema.

^†The total rate of medical events collected from the product complaint database was approximately 6%, with skin irritation due to adhesive components as the most reported event.

^‡Significant pain relief and/or improvement in quality of life defined as ≥ 50% pain relief and/or at least Minimally Improved on PGIC.

^**In a market research study, SPRINT PNS was a patient-preferred treatment.¹³

References

Chae J, et al. Am J Phys Med Rehabil. 2005;84(11): 832-842.
Gilmore C, et al. Pain Pract. 2020;20(3):310-320.
Gilmore C, et al. Reg Anesth Pain Med. 2020;45(1):44-51.
Gilmore C, et al. Interv Pain Med. 2023;2:100243.
Goree JH, et al. Neuromodulation. 2024;27:847861.
Gilmore et al. ASPN Poster 2024.
Yu D, et al., Arch Phys Med Rehabil. 2001;82(1):20-25.
Chae J, et al. Pain Pract. 2013;13(1):59-67.
Rauck RL, et al. Neuromodulation. 2014;17(2):188-197.
Wilson RD, et al. Am J Phys Med Rehabil. 2014;93(1):1728.
Wilson RD, et al. Neuromodulation. 2014;17(8):771-776.
Huntoon M, et al. Pain Phys. 2023;26:273-281.
Staats P, et al. Pain Mgmt. 2021;12(3):371-382.